AI assistant
Sending…
Marker Therapeutics, Inc. — Director's Dealing 2011
Apr 5, 2011
35150_dirs_2011-04-05_e30dd8ba-2fc2-46d6-8101-1287d46739a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TAPIMMUNE INC (TPIV)
CIK: 0001094038
Period of Report: 2011-03-23
Reporting Person: CORIN DENIS (Director, President and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-23 | Common Stock | J | 294118 | $0.17 | Acquired | 2227868 | Direct |
| 2011-03-23 | Common Stock | S | 160000 | $0.12 | Disposed | 135300 | Indirect |
Footnotes
F1: These shares were issued in lieu of $50,000 worth of accrued and unpaid salary.
More from Marker Therapeutics, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Annual Report
2026
Mar 18
Regulatory Filings
2026
Feb 9
Director's Dealing
2025
Nov 19
Director's Dealing
2025
Nov 19
Director's Dealing
2025
Nov 19
Major Shareholding Notification
2025
Nov 17